3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia
10
Leukemia, Lymphocytic, Chronic, B-Cell
9
Congenital Abnormalities
8
Leukemia, Myeloid, Acute
7
Breast Neoplasms
7
Multiple Myeloma
6
Lymphoma, Mantle-Cell
6
Waldenstrom Macroglobulinemia
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Burkitt Lymphoma
5
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large-Cell, Immunoblastic
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Squamous Cell Carcinoma of Head and Neck
3
Sezary Syndrome
3
Rectal Neoplasms
3
Mycosis Fungoides
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Myeloid, Accelerated Phase
3
Hodgkin Disease
3
Interventions
Gemcitabine
358
Fluorouracil
94
Oxaliplatin
81
Capecitabine
74
130-nm albumin-bound paclitaxel
71
Albumin-Bound Paclitaxel
70
Radiotherapy
67
Leucovorin
58
Irinotecan
49
Erlotinib Hydrochloride
47
Cisplatin
44
Bevacizumab
31
pembrolizumab
30
Radiosurgery
30
Docetaxel
26
Taxes
24
Nivolumab
24
Cetuximab
24
Pancreaticoduodenectomy
20
Drug Therapy
17
folfirinox
16
Cyclophosphamide
16
Radiation
15
Ipilimumab
13
Endoscopic Ultrasound-Guided Fine Needle Aspiration
13
Surgical Procedures, Operative
12
Sorafenib
12
Paclitaxel
12
Neoadjuvant Therapy
12
irinotecan sucrosofate
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pancreatic Neoplasms
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled